[go: up one dir, main page]

CU24203B1 - Composiciones de suministro de fármacos biodegradables - Google Patents

Composiciones de suministro de fármacos biodegradables

Info

Publication number
CU24203B1
CU24203B1 CUP2013000091A CU20130091A CU24203B1 CU 24203 B1 CU24203 B1 CU 24203B1 CU P2013000091 A CUP2013000091 A CU P2013000091A CU 20130091 A CU20130091 A CU 20130091A CU 24203 B1 CU24203 B1 CU 24203B1
Authority
CU
Cuba
Prior art keywords
compositions
supply
biodegradable
polyester
drugs
Prior art date
Application number
CUP2013000091A
Other languages
English (en)
Other versions
CU20130091A7 (es
Inventor
Georges Gaudriault
Original Assignee
Medincell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45809329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU24203(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medincell filed Critical Medincell
Publication of CU20130091A7 publication Critical patent/CU20130091A7/es
Publication of CU24203B1 publication Critical patent/CU24203B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se dan a conocer composiciones de suministro de fármacos biodegradables que comprenden un copolímero de tres bloques (tribloque) que contiene un poliéster y un polietilenglicol, y un copolímero de dos bloques (dibloque) que contiene un poliéster y un polietilenglicol tapado en los extremos, así como un principio farmacéuticamente activo.
CUP2013000091A 2010-12-29 2013-06-27 Composiciones de suministro de fármacos biodegradables CU24203B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428007P 2010-12-29 2010-12-29
PCT/IB2011/003323 WO2012090070A2 (en) 2010-12-29 2011-12-29 Biodegradable drug delivery compositions

Publications (2)

Publication Number Publication Date
CU20130091A7 CU20130091A7 (es) 2013-08-29
CU24203B1 true CU24203B1 (es) 2016-09-30

Family

ID=45809329

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2013000091A CU24203B1 (es) 2010-12-29 2013-06-27 Composiciones de suministro de fármacos biodegradables

Country Status (36)

Country Link
US (9) US9023897B2 (es)
EP (3) EP2658525B1 (es)
JP (2) JP6134269B2 (es)
KR (1) KR101741055B1 (es)
CN (1) CN103491946B (es)
AU (1) AU2011350898B2 (es)
BR (1) BR112013016662B1 (es)
CA (1) CA2822854C (es)
CL (1) CL2013001942A1 (es)
CO (1) CO6751290A2 (es)
CU (1) CU24203B1 (es)
CY (1) CY1119829T1 (es)
DK (1) DK2658525T3 (es)
EA (1) EA027046B1 (es)
ES (3) ES2733915T3 (es)
FI (1) FI3586825T3 (es)
HR (1) HRP20171810T1 (es)
HU (1) HUE037349T2 (es)
IL (1) IL227235A (es)
LT (1) LT2658525T (es)
MA (1) MA34832B1 (es)
ME (1) ME02915B (es)
MX (1) MX347090B (es)
MY (1) MY165655A (es)
NO (1) NO2658525T3 (es)
NZ (1) NZ612326A (es)
PL (3) PL3586825T3 (es)
PT (1) PT2658525T (es)
RS (1) RS56550B1 (es)
SG (2) SG10201508568VA (es)
SI (1) SI2658525T1 (es)
SM (1) SMT201700550T1 (es)
TN (1) TN2013000267A1 (es)
UA (1) UA112069C2 (es)
WO (1) WO2012090070A2 (es)
ZA (1) ZA201304687B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2866837B1 (en) * 2012-06-27 2022-12-14 Medincell S.A. Biodegradable drug delivery for hydrophobic compositions
WO2014099984A1 (en) 2012-12-20 2014-06-26 Amgen Inc. Apj receptor agonists and uses thereof
EP2896402A1 (en) 2014-01-20 2015-07-22 Vect-Horus Activated neurotensin molecules and the uses thereof
EP3099313B1 (en) 2014-01-27 2021-04-21 Centre National De La Recherche Scientifique Retro-inverso analogs of spadin display increased antidepressant effects
FR3027522B1 (fr) 2014-10-27 2016-12-09 I Ceram Composition poreuse chargee en principe actif
CN107427610B (zh) * 2015-03-12 2021-09-17 库罗斯生物科学有限公司 无水生物相容性复合材料
US20170079985A1 (en) 2015-09-21 2017-03-23 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations
EP4374861A3 (en) * 2015-11-16 2024-08-07 MedinCell S.A. A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
US20190343761A1 (en) 2016-11-16 2019-11-14 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
JP2020511483A (ja) 2017-03-20 2020-04-16 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ 徐放性オランザピン製剤
WO2019016234A1 (en) * 2017-07-17 2019-01-24 Medincell Pharmaceutical composition
US20210371600A1 (en) 2017-10-04 2021-12-02 Fashion Chemicals Gmbh & Co. Kg Novel Esters of Polylactic Acid And Compositions Thereof
GB201900258D0 (en) * 2019-01-08 2019-02-27 Medincell Pharmaceutical composition
JP7661312B2 (ja) * 2019-09-13 2025-04-14 メドインセルル エス．エー． 薬物送達製剤
CN110638963A (zh) * 2019-11-01 2020-01-03 慧生医学科技(徐州)有限公司 一种可降解缓释药物组合物及制备方法
GB202010340D0 (en) 2020-07-06 2020-08-19 Medincell Pharmaceutical composition
WO2022129417A1 (en) 2020-12-16 2022-06-23 Medincell Methods and compositions for the prophylactic treatment of sars-cov-2 virus (covid-19)
WO2022153262A1 (en) 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form
CA3208006A1 (en) 2021-03-17 2022-09-22 Avia MERENLENDER WAGNER Long acting injectable formulation comprising risperidone and biodegradable polymers
KR20240006032A (ko) * 2021-04-30 2024-01-12 메딘셀 에스.에이. 새로운 제형
EP4366726A1 (en) 2021-07-06 2024-05-15 Mark Hasleton Treatment of serotonin reuptake inhibitor withdrawal syndrome
CN118159252A (zh) 2021-08-05 2024-06-07 美蒂森股份公司 药物组合物
WO2024052920A1 (en) * 2022-09-08 2024-03-14 Ramot At Tel-Aviv University Ltd. Programmable stimuli-responsive polymeric formulations
SMT202500442T1 (it) 2023-01-10 2026-01-12 Medincell Sa Composizioni di olanzapina e metodi d'uso
WO2025104289A1 (en) 2023-11-17 2025-05-22 Medincell S.A. Antineoplastic combinations
WO2025224317A1 (en) * 2024-04-25 2025-10-30 Medincell S.A. A method for targeting pharmaceutically active principle in total knee replacement
WO2026013080A1 (en) 2024-07-08 2026-01-15 InnoCore Technologies Holding B.V. Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37983T1 (de) 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
EP0343850B1 (en) * 1988-05-23 1994-07-20 The Procter & Gamble Company Absorbent structures from mixed furnishes
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5632727A (en) 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5221534A (en) * 1989-04-26 1993-06-22 Pennzoil Products Company Health and beauty aid compositions
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US5565215A (en) 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
SG47445A1 (en) * 1993-11-19 1998-04-17 Janssen Pharmaceutica Nv Microencapsulated 3-piperidinyl-substituted1 1 2-benzisoxazoles and 1 2-benzisothiazoles
KR0148704B1 (ko) 1994-01-10 1998-08-17 김상응 생체분해성 약물전달용 고분자
DE69524398T2 (de) 1994-04-08 2002-07-18 Atrix Laboratories, Inc. Flüssige mittel zur wirkstoffabgabe
AU4652596A (en) 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
IL118235A0 (en) 1996-05-13 1996-09-12 Univ Ben Gurion Composition and method for forming biodegradable implants in situ and uses of these implants
US5711958A (en) * 1996-07-11 1998-01-27 Life Medical Sciences, Inc. Methods for reducing or eliminating post-surgical adhesion formation
US6541033B1 (en) 1998-06-30 2003-04-01 Amgen Inc. Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
KR100416242B1 (ko) 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
KR100446101B1 (ko) 2000-12-07 2004-08-30 주식회사 삼양사 수난용성 약물의 서방성 제형 조성물
US6592899B2 (en) * 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
AU2003222310B2 (en) * 2002-05-03 2009-04-09 Janssen Pharmaceutica N.V. Polymeric microemulsions
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US7160551B2 (en) 2002-07-09 2007-01-09 The Board Of Trustees Of The University Of Illinois Injectable system for controlled drug delivery
US20050112170A1 (en) * 2003-11-20 2005-05-26 Hossainy Syed F. Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same
US7262253B2 (en) * 2003-12-02 2007-08-28 Labopharm, Inc. Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers
US20060034889A1 (en) * 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
WO2006127953A2 (en) * 2005-05-23 2006-11-30 University Of Utah Research Foundation Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents
WO2007061896A1 (en) * 2005-11-17 2007-05-31 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
AR064286A1 (es) * 2006-12-13 2009-03-25 Quiceno Gomez Alexandra Lorena Produccion de dispositivos oftalmicos basados en la polimerizacion por crecimiento escalonado fotoinducida
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
AR070033A1 (es) 2007-11-06 2010-03-10 Panacea Biotec Ltd Composiciones inyectables, sus procesos y usos
JP2010215562A (ja) 2009-03-17 2010-09-30 Kansai Univ 膨隆剤組成物および膨隆剤製造方法

Also Published As

Publication number Publication date
EA027046B1 (ru) 2017-06-30
HRP20171810T1 (hr) 2017-12-29
HUE037349T2 (hu) 2018-08-28
US20120172454A1 (en) 2012-07-05
CO6751290A2 (es) 2013-09-16
JP6302983B2 (ja) 2018-03-28
US20190192665A1 (en) 2019-06-27
EP3586825A1 (en) 2020-01-01
AU2011350898A1 (en) 2013-07-11
CU20130091A7 (es) 2013-08-29
ES2647614T3 (es) 2017-12-22
PL2658525T3 (pl) 2018-02-28
US20220202942A1 (en) 2022-06-30
TN2013000267A1 (en) 2014-11-10
PL3586825T3 (pl) 2023-04-11
RS56550B1 (sr) 2018-02-28
SMT201700550T1 (it) 2018-01-11
US20230091533A1 (en) 2023-03-23
JP2017039758A (ja) 2017-02-23
EP3257498B1 (en) 2019-04-24
MX2013007682A (es) 2013-10-30
FI3586825T3 (fi) 2023-03-20
KR20130135294A (ko) 2013-12-10
US9023897B2 (en) 2015-05-05
US20210038724A1 (en) 2021-02-11
ZA201304687B (en) 2014-03-26
CY1119829T1 (el) 2018-06-27
CL2013001942A1 (es) 2014-07-04
US20150157727A1 (en) 2015-06-11
EP2658525B1 (en) 2017-08-30
NO2658525T3 (es) 2018-01-27
JP6134269B2 (ja) 2017-05-24
CN103491946B (zh) 2016-08-10
WO2012090070A2 (en) 2012-07-05
US20160030581A1 (en) 2016-02-04
EP2658525A2 (en) 2013-11-06
EP3257498A1 (en) 2017-12-20
SG10201508568VA (en) 2015-11-27
WO2012090070A3 (en) 2012-11-01
JP2014502613A (ja) 2014-02-03
MY165655A (en) 2018-04-18
BR112013016662A2 (pt) 2016-10-04
BR112013016662B1 (pt) 2021-08-03
LT2658525T (lt) 2017-12-11
MA34832B1 (fr) 2014-01-02
MX347090B (es) 2017-04-11
CA2822854C (en) 2020-01-07
EA201390783A1 (ru) 2013-12-30
EP3586825B1 (en) 2023-01-18
SI2658525T1 (en) 2018-04-30
PL3257498T3 (pl) 2020-02-28
UA112069C2 (uk) 2016-07-25
CA2822854A1 (en) 2012-07-05
US20190099495A1 (en) 2019-04-04
NZ612326A (en) 2014-10-31
CN103491946A (zh) 2014-01-01
SG191414A1 (en) 2013-08-30
AU2011350898B2 (en) 2016-09-08
US20210154301A1 (en) 2021-05-27
IL227235A (en) 2016-05-31
WO2012090070A8 (en) 2013-08-08
ES2939744T3 (es) 2023-04-26
DK2658525T3 (da) 2017-11-13
ME02915B (me) 2018-04-20
PT2658525T (pt) 2017-11-30
ES2733915T3 (es) 2019-12-03
KR101741055B1 (ko) 2017-05-29

Similar Documents

Publication Publication Date Title
CU20130091A7 (es) Composiciones de suministro de fármacos biodegradables
CO7160098A2 (es) Suministro de fármaco biodegradable para las composiciones hidrofóbicas
PE20141671A1 (es) Forma de dosis farmaceutica oral a prueba de manipulacion que comprende un agente antagonista y/o repelente opioide, oxido de polialquileno y un polimero anionico
MX2009010289A (es) Composiciones para administracion nasal.
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
NZ700397A (en) Block copolymers for stable micelles
EP2643009A4 (en) COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
AR059358A1 (es) Formulaciones farmaceuticas
AR113248A1 (es) Mezclas de composiciones biodegradables que modulan la cinética de liberación de al menos un ingrediente activo en la administración de fármacos
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
EP3124044C0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANATOXINS A AND B OF CLOSTRIDIUM DIFFICILE
PL2281576T3 (pl) Polimerowa micela typu aktywnie ukierunkowującego, niosąca zamknięty w niej lek i kompozycja medyczna
EP4374861A3 (en) A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
CY1121852T1 (el) Μορφοποιησεις και μεθοδοι παρασκευης μορφοποιησεων για χρηση στον καθαρισμο του παχεος εντερου
WO2012158448A3 (en) Compositions comprising siloxane polymer
PH12013500882A1 (en) Pharmaceutical compositions
NZ702849A (en) Genotype- or phenotype-based drug formulation
WO2013177147A3 (en) Copolymer-xerogel nanocomposites useful for drug delivery
MA33055B1 (fr) Nouvelle combinaison de principes actifs contenant un anti-inflammatoire non steroidien et un derive de colchicoside
PE20140675A1 (es) Comprimido farmaceutico de liberacion controlada para administracion oral
TH151376A (th) องค์ประกอบลำเลียงยาที่ย่อยสลายได้ทางชีวภาพ
AU2013901223A0 (en) Biodegradable network polymers for regenerative medicine and tissue engineering

Legal Events

Date Code Title Description
FG Grant of patent